CS
EIDX

Candriam SCA’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Candriam SCA’s Portfolio EIDX Stock Details EIDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$8.89M Sell
2020
Q3 		$9.38M Hold
2020
Q2 		$8.85M Buy
2020
Q1 		$9.64M Hold
2019
Q4 		$9.86M Sell
2019
Q3 		$7.88M Sell
2019
Q2 		$9.99M Sell
2019
Q1 		$9.97M Buy
2018
Q4 		$2M Buy